Skip to content
From the Blog: A Comprehensive Guide to Your Business Exit Options
Read Here
  • About
    • Team
    • Careers
  • Investment Banking Group
    • Industries
      • Business Services
      • Consumer
      • Healthcare Tech & Services
      • Life Sciences Services & Tech
      • Manufacturing & Distribution
      • Technology
    • M&A Clients
  • Valuation Group
    • Financial Reporting
      • Purchase Price Allocation (PPA), ASC 805
      • Funds/Portfolio Company Valuations, ASC 820
      • Goodwill Impairment, ASC 350
      • Complex Financial Instruments, ASC 815
      • Compensation, ASC 718
    • Strategic Advisory
      • Business Buy/Sell Evaluation (BEV)
      • Transaction/Exit Planning
      • Strategic Decision Support
      • Litigation Planning​
      • Financial Modeling & Deal Analysis
      • Business Planning & Pitchbook Preparation​
    • Tax Advisory
      • IRC 409A Valuations
      • Estate & Gift
      • Corporate Restructuring
      • Fair Market Value​
      • Intellectual Property
    • Transaction Opinions
      • ESOP
      • Fairness Opinions
      • Recapitalization/Solvency Opinions
    • Valuation Clients
  • Content Hub
  • Our Work
  • About
    • Team
    • Careers
  • Investment Banking Group
    • Industries
      • Business Services
      • Consumer
      • Healthcare Tech & Services
      • Life Sciences Services & Tech
      • Manufacturing & Distribution
      • Technology
    • M&A Clients
  • Valuation Group
    • Financial Reporting
      • Purchase Price Allocation (PPA), ASC 805
      • Funds/Portfolio Company Valuations, ASC 820
      • Goodwill Impairment, ASC 350
      • Complex Financial Instruments, ASC 815
      • Compensation, ASC 718
    • Strategic Advisory
      • Business Buy/Sell Evaluation (BEV)
      • Transaction/Exit Planning
      • Strategic Decision Support
      • Litigation Planning​
      • Financial Modeling & Deal Analysis
      • Business Planning & Pitchbook Preparation​
    • Tax Advisory
      • IRC 409A Valuations
      • Estate & Gift
      • Corporate Restructuring
      • Fair Market Value​
      • Intellectual Property
    • Transaction Opinions
      • ESOP
      • Fairness Opinions
      • Recapitalization/Solvency Opinions
    • Valuation Clients
  • Content Hub
  • Our Work
Contact Us

Newsletter

The Objective Newsletter

Your essential resource for navigating M&A strategy and valuation. Delivered right to your inbox.

Subscribe Today

Newsletter Archive

Valuation

The Provider Attention Gap for High-Context Clients

Read More »
June 3, 2026
News

Cody McPherson and Benjamin Stenson Announced as Winners of the 17th Annual Emerging Leaders Awards

Read More »
May 26, 2026
Business Buy:Sell Evaluation
Valuation

Are You an “Automated Platform Graduate”? What This Means for Your 409A Valuation

Read More »
May 18, 2026
News

The Defining Theme of the 2026 EOS Conference: Fulfilled People Build Stronger Companies

Read More »
May 8, 2026
News

Objective Advises Production Elements Inc. on Its Sale to Arena Americas, a Modon Company

Read More »
April 23, 2026
Investment Banking

Objective Investment Banking & Valuation Recognized as 2026 Banking & Finance Visionaries by L.A. Times

Read More »
March 24, 2026
Load More
The next step in your future.
Let's Talk
Objective-CP-Logo_White
What We Do
  • Investment Banking Group
  • Valuation Group
Industry Practices
  • Business Services
  • Consumer
  • Healthcare Tech & Services
  • Life Sciences Services & Tech
  • M&A Manufacturing & Distribution
  • Technology Investment Banking
Explore Objective
  • About
  • Careers
  • Team
  • Resources
  • Content Hub
  • Contact
Contact Us
  • *Registered Office Address (Does Not Accept Mail) : 11622 El Camino Real, Suite 100, San Diego, CA, 92130
  • [email protected]
  • Contact us
Locations
  • Los Angeles, California
  • San Diego, California
  • Orange County Investment Banking
  • Investment Banking, Southern California
  • Business Valuation Denver
  • Business Valuation Colorado
CONNECT ON LINKEDIN

Investment Banking Services are offered through BA Securities, LLC. Member FINRA SIPC.  Objective, Investment Banking & Valuation (“Objective”) and BA Securities, LLC are separate, unaffiliated entities. To learn more about the professional background of Objective and our Registered Representatives, please visit FINRA BrokerCheck. Past performance, awards, or testimonials are not indicative of future results. No guarantee of future performance or success is implied.

*Denotes engagements completed by an Objective Principal prior to joining Objective

Registered Office Address is for legal and administrative purposes only. Please do not send mail or visit in person.

Copyright 2023 © Objective, Investment Banking & Valuation. All rights reserved. 

Sitemap

Privacy Policy

Terms of use